COMMENTARY
O ne of the most common consultations that occurs in an epileptologist's clinic involves an unexpected or anomalous EEG report; for instance, a physician sends a patient with a classic syncopal episode for an EEG and then is taken aback when the results are consistent with, or even diagnostic of, epilepsy. The uneasy physician, who sensibly hesitates to make the diagnosis of epilepsy, sends both the patient and the EEG to an epileptologist, who finds a benign paroxysmal or sharp pattern on the tracing. Seventy years after the discovery of the EEG and its widespread validation as a useful diagnostic procedure, why does this happen? There are several potential reasons, including: (1) shrinking time to train doctors to read EEGs, within modern, busy neurology residency programs, (2) the inherent subjectivity of pattern recognition applied to a complex signal, and (3) the undoubtedly ambiguous appearance of various morphological patterns, some of which can even give pause to the experienced electroencephalographer.
Current problems in misreading EEGs may have their origins in the initial applications of electroencephalographya procedure that was enthusiastically received in the 1940s and 1950s as a revelatory diagnostic tool for conditions from psychosis to migraine. Early clinical EEG studies associated certain EEG patterns with specific diseases, producing published reports such as: "EEG patterns in_______[insert name of disease]," with little or no use of an appropriate comparison population and sometimes with no direct knowledge of the patients being recorded. This practice led to overblown claims for the diagnostic specificity of the electroencephalogram. In addition, unusual or puzzling symptoms sometimes were linked with morphologically sharp or paroxysmal patterns thought to suggest the presence of epilepsy. A 1963 paper, for example, reported the findings of 5,000 consecutive EEGs, describing 253 patients with "psychomotor variant" waves (i.e., rhythmic temporal theta discharges), associated with "ictal symptoms, such as fainting attacks, crying spells, rage attacks" and other "epileptoid" [sic] phenomena (1) . In the early 1950s, an EEG with 14 and 6 positive spikes was even produced by defense attorneys as purported evidence of an organic brain disorder to explain a homicide by their client (2) .
The EEG patterns included in the study by Santoshkumar et al., reviewed here, are the most common and easily characterized EEG variants initially thought to be associated with epilepsy, but which eventually proved to be present just as often in healthy people. The fact that these patterns are infrequently identified in routine recordings probably has contributed to their durability as a speciously abnormal finding. These benign EEG variants were debated and identified as controversial patterns, and today standard EEG textbooks include them as normal patterns and as variants only insofar as they are not seen in the majority of EEGs. The study by Santoshkumar et al. does nothing to add yet another nail in the coffin of the pathogenicity of benign epileptiform variants, as it is simply a survey of their incidence in an unselected population of patients referred to an outpatient EEG laboratory. As such, the study's greatest value may lie in the implications about the methods used in contemporary, routine EEG recording and reading.
The prevalence figures the investigators reported are remarkably low, ranging from 0.07% for subclinical rhythmic electrographic discharges of adults (SRDA) to 1.85% for benign sporadic sleep spikes (i.e., benign epileptiform transients of sleep, or BETS). In comparison, in 1977 White et al. found BETS (also known as small sharp spikes) in 20% of consecutive patients referred for diagnostic EEGs for a variety of symptoms and disorders (3) . They also studied a cohort of healthy young teens as a comparison group and discovered BETS in 24% of them. Similarly, in 1966 Lombroso et al. prospectively studied the EEGs of 212 healthy young teens, looking for 14 and 6 positive spikes, which they called "ctenoids" (4) . Their subjects were deliberately prevented from sinking into any but the lightest sleep stages by loud noises during the recording. Using this unusual protocol, an amazing 58% of the teens were said to show the pattern.
Early EEGs were recorded with referential montages, generally using linked ears or unilateral ear references. Most of the benign patterns under consideration have widespread, shallow fields and are generally poorly seen or not seen at all with the bipolar montages that have more commonly been in use in recent years. The EEGs showing a high incidence of 14 and 6 positive spikes recorded by Lombroso et al., for example, were performed exclusively with referential montages.
As the pathological basis for these patterns became increasingly discredited, EEG assessments simultaneously changed. The EEGs reviewed by Santoshkumar et al. date from 1972 to 2007, so the great majority of them were read by expert electroencephalographers who most likely accepted the benign nature of the discharges. Thus, these experts may not have felt impelled to take the time to enter into the database every pattern not seen in a so-called typical or normal EEG; thus these benign epileptiform variants may often have been ignored. Because of the retrospective nature of the study, the readers presumably were not specifically reviewing the EEGs looking for these patterns.
The problem of misleading or incorrect EEG interpretation has not entirely been solved by the eventual clarification of these variants, however. Many erroneous EEG interpretations do not arise from these patterns, but rather from more subtle over-reading of sharply formed normal patterns. Among a group of patients with clinically obvious syncope or proven pseudoseizures, Benbadis et al. reviewed 15 EEGs that had been read as containing epileptiform activity (5) . Only one EEG showed wicket spikes, while other activity which was spuriously interpreted as epileptiform consisted of hypnagogic hypersynchrony, hyperventilation induced slowing, or most commonly, simply fluctuations of sharply contoured background activity. The answer to such misinterpretations can be solved only through better education in EEG pattern recognition and assessment-during and after basic neurological training. fifty-three patients with probable AD observed prospectively from mild disease stages since 1992. MAIN OUTCOME MEASURE: Informant interviews every 6 months included questions about whether the patient had a seizure (convulsion, fainting, or "funny" spell) and whether diagnosis or treatment for epilepsy or seizure was made. Two epileptologists independently retrospectively reviewed all available medical records for 52 patients with positive responses to either of these questions, and using a specific checklist form, events were diagnosed as to whether they were unprovoked seizures (intrarater concordance, κ = 0.67). Diagnosis of unprovoked seizures constituted the event in survival analyses. Potential predictors included sex, age, race/ethnicity, educational achievement, duration of illness, baseline cognition and function, depression, medical comorbidities, and time-dependent use of cholinesterase inhibitors and neuroleptic agents, apolipoprotein E genotype, and previous electroencephalographic findings. RESULTS: Over the course of 3,518 visit-assessments (per patient: mean, 7.8; maximum, 27), 7 patients (1.5%) developed seizures. Younger age was associated with higher risk (hazard ratio, 1.23; 95% confidence interval, 1.08-1.41; P = .003 for each additional year of age) of seizure incidence. No other predictor was significant. The overall incidence of seizures was low (418 per 100 000 person-years of observation) although significantly higher than expected for idiopathic unprovoked seizures in similar age ranges of the general population (hazard ratio, 8.06; 95% confidence interval, 3.23-16.61). CONCLUSIONS: Unprovoked seizures are uncommon in AD, but they do occur more frequently than in the general population. Younger age is a risk factor for seizures in AD.
T he incidence of epilepsy increases progressively in old age, with the highest incidence rates recorded after age 75 years (1) . New onset epilepsy in the elderly is usually symptomatic, even though a considerable proportion of patients have no identified etiology. In one study, the most commonly recognized etiology was cerebrovascular disease, accounting for about one-third of patients older than 64 years, while degenerative disease accounted for 11.5% of patients (1). Alzheimer's disease, the most common degenerative disease of the CNS and the most common cause of dementia, is a recognized risk factor for epilepsy. For example, 8 of 81 patients with autopsy-confirmed disease developed unprovoked seizures after the onset of dementia, reflecting an incidence that is 10 times higher than expected (2) . Subsequent studies showed even higher proportion of affected patients: in one study, 7 of 44 patients (16%) with Alzheimer's disease developed generalized tonic-clonic seizures as compared to none of 58 healthy controls (3). Three of these patients had autopsies that failed to identify any neuropathologic epileptogenic factors, other than Alzheimer's disease. In another study, 77 (17%) of 446 patients with autopsy-confirmed Alzheimer's disease developed unprovoked seizures (4). The patients with seizures had a younger age of dementia onset than patients who did not develop seizures, but seizures were usually a late feature, seen with advanced disease, on average at 6.8 years after onset. An even higher incidence of seizures (21%) was reported among institutionalized patients with Alzheimer's disease (5) . The clinical association between seizures and Alzheimer's disease is supported by experimental evidence. For instance, high levels of β-amyloid, the main constituent of Alzheimer plaques, caused epileptiform activity in a mouse model (6) . In addition, presence of the apolipoprotein E-ε4 allele, a major genetic risk factor for Alzheimer's disease, is also associated with increased risk of late post-traumatic seizures (7).
In the current study, Scarmeas et al. also concluded that Alzheimer's disease was a risk factor for unprovoked seizures and that younger age was a predictor, however they found a much lower incidence than previously reported. The reason for the discrepancy between this and other published studies may be that patients were enrolled in the early stages of the disease in the Scarmeas et al. trial. Another important differentiating factor may be the rigorous criteria used for the diagnosis of seizures: two epileptologists had to reach an agreement on the diagnosis, after considering the available data. While only seven patients were eventually considered to have had unprovoked seizures, 45 others gave at least one positive response to Epilepsy Currents, Vol. 10, No. 2 (March/April) 2010 pp. 36-37 Wiley Periodicals, Inc. C American Epilepsy Society the seizure-related questions used in the study. Only nine events were considered nonepileptic, based on adequate data. The remaining 36 events could not be classified because of insufficient information. When these 36 events were included as seizures, the estimated risk of unprovoked seizures with Alzheimer's disease increased to 13%, at 5 years from inclusion in the study.
It is likely that the current study and other studies may have missed seizures that lacked a prominent motor component, such as complex partial seizures manifesting mostly with altered awareness and responsiveness. Even though one recent study suggested that complex partial seizures may be the most common seizure type in dementia (8) , six of the seven (86%) seizures reported in the current study were convulsive; and in another study, 69 of 77 (90%) of patients had generalized tonic-clonic seizures (4). Patients with Alzheimer's disease may not be able to report subjective experiences associated with complex partial seizures, and observers may find it difficult to distinguish confusion and altered responsiveness that is due to seizures from similar manifestation that result from fluctuations in dementia.
Seizures associated with Alzheimer's disease appear to be infrequent. The current study reported that four patients had only a single seizure. Another study reported 71% of affected patients had less than three seizures each (4) . Such data raise the question of whether these single seizures have to be treated. However, as discussed, mild complex partial seizures may not be recognized in this patient population; thus, it is quite possible that the recurrence rate is underestimated. The recurrence rate after a single, unprovoked seizure is estimated as high as 80% in the elderly (9) , and antiepileptic drug (AED) therapy is therefore recommended after a single seizure in this age group. In the current study, five of the seven patients with seizures were treated with an AED. Epilepsy in the elderly is generally responsive to AED therapy at low doses (9) . In one recent series, 79% of patients with recurrent seizures and Alzheimer's dementia were reported to have an excellent response to AED therapy (8) . Using a single nonenzyme-inducing AED, at a low dose, may help avoid interactions and adverse experiences among these patients, who are likely to be receiving other medications as well. If seizures fail to come under control, it is important to consider the potentially proconvulsant effect of acetylcholinesterase inhibitors, which frequently are used for the treatment of dementia. The current study did not find the use of these agents to be a predictor of unprovoked seizures. However, other investigators have provided evidence that they may exacerbate seizures in patients with epilepsy (10) .
The relationship between dementia and epilepsy is not exclusively one directional, with the dementing illness possibly causing epilepsy, as importantly, new onset epilepsy in the elderly may present with cognitive decline and may be misdiagnosed as a progressive dementia (11, 12) . In such instances, cognitive function improves and stabilizes with successful therapy, making it unlikely that seizures are an initial presentation of Alzheimer's disease. In addition, dementia can be a result of adverse cognitive effects from AEDs; for instance, valproate therapy among elderly patients has been associated with a reversible syndrome of cognitive impairment and Parkinsonism (13) . It is possible that patients with epilepsy or AED-induced cognitive impairment may inflate the apparent incidence of epilepsy in the setting of dementia. The determination that seizures are secondary to Alzheimer's disease can be made with most confidence when seizures appear as a late feature, after years of progressive dementia. When seizures and dementia start at around the same time, there is an increased likelihood that the dementia may be a consequence of epilepsy or its therapy rather than of true Alzheimer's disease. large, prospective, community-based study characterized neuropsychological functioning and academic achievement at the time of the first recognized seizure and identified risk factors for cognitive deficits. METHODS: We compared 282 children (ages 6-14 years, IQ ≥ 70) with a first recognized seizure to 147 healthy siblings on a battery of well-standardized and widely used neuropsychological and academic achievement tests and examined relationships with demographic and clinical variables. RESULTS: In this intellectually normal cohort, 27% with just one seizure and up to 40% of those with risk factors exhibited neuropsychological deficits at or near onset. Risk factors associated with neuropsychological deficits included multiple seizures (i.e., second unprovoked seizure; odds ratio [OR] = 1.96), use of antiepileptic drugs (OR = 2.27), symptomatic/cryptogenic etiology (OR = 2.15), and epileptiform activity on the initial EEG (OR = 1.90); a child with all 4 risks is 3.00 times more likely than healthy siblings to experience neuropsychological deficits by the first clinic visit. Absence epilepsy carried increased odds for neuropsychological impairment (OR = 2.00). CONCLUSIONS:
A subgroup of intellectually normal children with seizures showed neuropsychological deficits at onset. Academic achievement was unaffected, suggesting that there is a window early in the disorder for intervention to ameliorate the impact on school performance. Therefore, the risk factors identified here (especially if multiple risks are present) warrant swift referral for neuropsychological evaluation early in the course of the condition.
C ognitive and behavioral comorbidities have long been recognized among patients with epilepsy, although the timing of their appearance has been difficult to research because of a number of methodological issues. Several reports have suggested that cognitive impairment may present at or even predate the appearance of the initial seizure (1,2). However, these studies typically have been limited in value as a result of small sample sizes, gross measures of neuropsychological outcomes, absence of appropriate controls, or exclusion of seizure types and seizure etiologies that decrease the ability to generalize the findings.
Many of these drawbacks were overcome by Fastenau et al. in a relatively large-scale, community-based prospective study of children with newly diagnosed epilepsy. In this report, 292 children with epilepsy were identified at the time of diagnosis or soon thereafter; their neuropsychological and achievement profiles were compared to sibling controls (n = 147), using a battery of well-recognized measures. Although children with new onset epilepsy performed more poorly than their siblings on most of the neuropsychological tests administered, they did not differ on measures of academic achievement, suggesting that poorer cognitive abilities had not yet begun to negatively affect school performance. Because the child cohort enrollment was community-based, rather than recruited from specialized epilepsy clinics, the results are relatively representative of the population of new onset pediatric epilepsy cases.
While neuropsychological impairment at the time of epilepsy diagnosis has been reported previously, the size, overall representation of the subjects enrolled, and sibling controls make this an important study, confirming the risk of decreased cognitive abilities at the time of epilepsy diagnosis-a risk that is not limited to patients with the severe epilepsy syndromes. However, even stronger findings would have been achieved if the sample had not been restricted to children with so-called normal IQ estimates (i.e., IQs ≤ 70). Just as previous studies that excluded children based on seizure type or etiology limited the clinical usefulness of the data, exclusion of patients based on IQ restricts the generalizability of these results. An exclusion criterion based on IQ, when cognitive performance is a primary outcome variable, biases the sample such that the frequency and magnitude of any observed effect will be underestimated. Thus, the true frequency of cognitive impairment in new onset pediatric epilepsy will be higher than the 27 to 40 percent reported.
This study employed the Kaufman Brief Intelligence Test (K-BIT) for the IQ estimate, rather than the Wechsler Intelligence Scale for Children-IV (WISC-IV), which is considered the gold standard for IQ assessment of children in North America. However, the K-BIT yields scores that may range from as many as 25 IQ points lower to as many as 24 point higher than the WISC-III (3). Thus, in creating a sample of children with normal IQ by excluding those with IQ estimates below 70, unnecessary noise has been introduced, given the poor relationship between WISC-IV and K-BIT IQ scores on the individual patient level.
Despite these limitations, the study highlights that cognitive impairment is a core feature of many pediatric epilepsy Epilepsy Currents, Vol. 10, No. 2 (March/April) 2010 pp. 38-39 Wiley Periodicals, Inc. C American Epilepsy Society syndromes, including the so-called benign epilepsy syndromes, and cannot solely be attributed to the effects of recurrent seizures or side effects of pharmacotherapy. Although neuropsychological impairment may be present in many children at the time of epilepsy diagnosis, academic achievement appears normal, suggesting that there is a window of opportunity during which appropriate interventions might decrease the burden of cognitive loss. This assessment raises the question of whether all newly diagnosed children with epilepsy should be referred for neuropsychological testing. At a minimum, these findings indicate that the referral threshold should be sufficiently low to prevent appropriate patient evaluations from being missed. Another approach to assess intervention needs could be a twostage process, similar to what is used to identify dementia in many geriatric clinics, in which patients receive brief cognitive screening and neuropsychological referrals are made based on that screening.
Although a focus on noncognitive behavioral abnormalities is apparent, the study did not report other neurobehavioral conditions, such as Attention Deficit Hyperactivity Disorder (ADHD) or mood disturbances, which also may be present at the time of initial epilepsy diagnosis (4, 5) . Thus, the degree to which cognitive and psychiatric comorbidities overlap or exist independently among children with new onset epilepsy remains unanswered. When considered together, the actual incidence of neurobehavioral comorbidities at the time of initial diagnoses-defined as either cognitive impairment, ADHD, or mood disturbance-is remarkably high and remains to be properly assessed. A paper by Hermann and colleagues addresses the issue of whether combined or single comorbidities lead to poorer neurobehavioral prognosis. The authors studied children with new onset epilepsy and found that children with either ADHD or academic problems were not only worse neuropsychologically at baseline but also had a poorer 2-year cognitive trajectory across all cognitive domains, particularly for executive functioning (6) . In contrast, those children who did not present with neuropsychological and/or neurobehavioral comorbidities not only had normal neuropsychological status at baseline but also displayed a normal rate of cognitive development over the 2-year interval, as compared to controls. This finding suggests the benefits of early identification of children with neuropsychological deficits, so that appropriate interventions can be performed to maximize long-term cognitive outcomes.
The findings of Fastenau et al. have significant implications for schools, since important neuropsychological impairment in areas necessary for academic success (e.g., attention/executive function) are seen prior to development delays in achievement performance, even in the absence of an effect on gross neuropsychological measures, such as full-scale IQ measures. Thus, schools that approach children with epilepsy in a manner similar to students who have sustained traumatic brain injury, for which neuropsychological evaluation is suggested, will benefit these students by facilitating the development and implementation of Individual Education Plans as well as by identifying children who may require tutoring or additional time for test taking (7) . Such an approach, in turn, can provide greater awareness of cognitive comorbidities in the larger educational community, so that queries, such as how the diagnosis of complex partial seizures disorder is related to the need for extra time on standardized tests, no longer arise and parents and teachers of children with epilepsy can work closely together to allow these children to realize their full academic potential. 
T his amazing study by Chen et al. of neonates born to mothers with epilepsy shows an association between the risk of being small for gestational age (SGA) and the occurrence of seizures during pregnancy. Women with epilepsy who did not have seizures during pregnancy did not have an increased risk of SGA offspring compared to the offspring of healthy control mothers. Their findings reveal an important and clinically meaningful adverse outcome for neonates born to women with epilepsy. In the absence of maternal infection or illicit drug use, which are known causes of SGA, an evaluation for potential genetic causes of SGA and increased vigilance for perinatal complications, such as perinatal asphyxia, meconium aspiration, and hypoglycemia, are warranted in this patient population.
Identifying an association between SGA and seizures during pregnancy is novel. An association between women with epilepsy taking antiepileptic drugs (AEDs) and a doubled risk for SGA among in utero AED-exposed offspring has been found (1). Remarkably, the usual confounder for similar trialsmaternal AED use-was not present in the Chen et al. investigation, since many women in this geographic region are untreated, and women with epilepsy who were taking medications were excluded from the group used for analysis (2) . The study was performed by cross-referencing two national databases in Taiwan, those of women who had single births and those of women who were diagnosed with epilepsy between 2001 and 2003. The diagnosis of epilepsy in this subset of women was supported by documentation that included at least three consensus diagnoses of epilepsy or convulsions within the 2 years prior to the index delivery.
The risk of SGA among the offspring of women with epilepsy who had seizures during pregnancy, compared to women with epilepsy who did not have seizures during pregnancy, was mildly elevated, at an odds ratio of 1.34. Even the fairly tight 95% confidence intervals (i.e., 1.01-1.84) do not exclude the possibility of a moderate risk for an increased rate of SGA, although they do exclude a doubled risk. The authors also compared the women with epilepsy and a healthy control group and found an increased risk of low birth weight and preterm delivery among the women who had seizures, even after controlling for socioeconomic factors. Again, AED use was not a potential confounder; in fact, 84% of the women with epilepsy in this study (850 out of 1,016) were not taking AEDs. This dataset is one that likely would not be available in other parts of the world where similar surveillance of pregnant women with epilepsy is ongoing (e.g., the European Pregnancy Registry [EURAP] study and the North American Pregnancy Registry), as most patients in these trials are taking AEDs.
Additional valuable data could come from this dataset, such as whether there is a risk of birth defects related to seizures and epilepsy during pregnancy-a question that has long been unsatisfactorily answered, because the data have been confounded by the risks imparted by AEDs or by the likelihood that the epilepsy in the untreated group is mild or even questionable, making the comparison groups fundamentally different at baseline. Of note, previous studies have shown a lower risk Epilepsy Currents, Vol. 10, No. 2 (March/April) 2010 pp. 40-41 Wiley Periodicals, Inc. C American Epilepsy Society of adverse pregnancy outcomes in untreated women, but the data have been confounded by the possibility that these women had less severe epilepsy. This study adds credence to this theory, since it appears that women without seizures (i.e., with milder epilepsy) did better than those with severe (active) epilepsy. The finding indicating that epilepsy, itself, is an adverse factor for pregnancy outcomes, in comparison to healthy controls, is provocative and needs further investigation and clarification.
This study provides additional evidence that can be used to counsel patients that it is best to try to maintain seizure control during pregnancy. These data are sorely needed, given that clinicians still struggle to communicate effectively with pregnant women with epilepsy to impress upon them exactly why preventing seizures during pregnancy is important, as prospective mothers usually are instead focused primarily on the risks to the fetus associated with AED use.
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